Zabransky R J
Department of Pathology, University of Texas Medical Branch, Galveston 77555-0743.
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1025-31. doi: 10.1007/BF01967794.
In the USA, the National Committee for Clinical Laboratory Standards has studied and published a reference agar dilution method for the susceptibility testing of anaerobic bacteria. While numerous investigators both in Europe and the USA have evaluated a variety of methods with a variety of modifications, only the broth microdilution method appears to be appropriate for routine use. The problems of the choice of breakpoint, inoculum size, media, media additives, endpoint recognition and other parameters affecting test performance and interpretation, while troublesome for anaerobes, are not unique to this group of organisms. The increasing resistance of anaerobes and the ever existing need to provide therapeutic guidance, surveillance for resistance and susceptibility data on new drugs make the need for an accurate and reliable susceptibility test for anaerobes critical. The newer methods, while showing promise, need further evaluation with all agents that have a therapeutic indication for anaerobic infections.
在美国,国家临床实验室标准委员会已研究并发布了一种用于厌氧菌药敏试验的参考琼脂稀释法。尽管欧美众多研究人员对多种经过各种改良的方法进行了评估,但似乎只有肉汤微量稀释法适合常规使用。断点选择、接种量、培养基、培养基添加剂、终点识别以及其他影响试验性能和结果判读的参数等问题,虽然对厌氧菌来说很棘手,但并非这类微生物所特有。厌氧菌耐药性的不断增加以及始终存在的提供治疗指导、监测耐药性和新药药敏数据的需求,使得对厌氧菌进行准确可靠的药敏试验变得至关重要。较新的方法虽显示出前景,但需要对所有有治疗厌氧菌感染指征的药物进行进一步评估。